These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2598971)

  • 1. Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects.
    Rey E; Luquel L; Richard MO; Mory B; Offenstadt G; Olive G
    Eur J Clin Pharmacol; 1989; 37(4):387-9. PubMed ID: 2598971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperkalaemia with intravenous salbutamol.
    Murdoch IA; Dos Anjos R; Haycock GB
    Arch Dis Child; 1991 Apr; 66(4):527-8. PubMed ID: 2031614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperkalemia in children with intravenous salbutamol.
    Noyan A; Anarat A; Pirti M; Yurdakul Z
    Acta Paediatr Jpn; 1995 Jun; 37(3):355-7. PubMed ID: 7645387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure.
    Liou HH; Chiang SS; Wu SC; Yang WC; Huang TP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):276-81. PubMed ID: 8039040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
    Liou HH; Chiang SS; Wu SC; Huang TP; Campese VM; Smogorzewski M; Yang WC
    Am J Kidney Dis; 1994 Feb; 23(2):266-71. PubMed ID: 8311086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
    Arias-Reyes JA; Matos-Martínez M; Velásquez-Jones L; Dubey-Ortega LA
    Bol Med Hosp Infant Mex; 1989 Sep; 46(9):603-6. PubMed ID: 2604875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
    McClure RJ; Prasad VK; Brocklebank JT
    Arch Dis Child; 1994 Feb; 70(2):126-8. PubMed ID: 8129434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol.
    Kemper MJ; Harps E; Hellwege HH; Müller-Wiefel DE
    Eur J Pediatr; 1996 Jun; 155(6):495-7. PubMed ID: 8789768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaler salbutamol for acute hyperkalemia in renal failure.
    Mocan MZ; Mocan G; Mocan H; Gorçin B
    Isr J Med Sci; 1993 Jan; 29(1):39-41. PubMed ID: 8454446
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.
    Kim HJ
    J Korean Med Sci; 1997 Apr; 12(2):111-6. PubMed ID: 9170015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
    de Cornelissen F; Bermudes H; Saint-Loubert M; Marty L; Emond C; Fontanier P
    Presse Med; 1989 Jun; 18(25):1243-4. PubMed ID: 2525773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid correction of acute hyperkalemia with nebulized salbutamol].
    Leanza HJ; Rivarola G; Graciela García M; Najun Zarazaga CJ; Casadei D
    Medicina (B Aires); 1992; 52(2):99-102. PubMed ID: 1308916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia: therapeutic options in acute and chronic renal failure.
    Kemper MJ; Harps E; Müller-Wiefel DE
    Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.
    Morgan DJ; Paull JD; Richmond BH; Wilson-Evered E; Ziccone SP
    Br J Clin Pharmacol; 1986 Nov; 22(5):587-93. PubMed ID: 3790406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
    Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE
    Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol infusion to treat neonatal hyperkalaemia.
    Greenough A; Emery EF; Brooker R; Gamsu HR
    J Perinat Med; 1992; 20(6):437-41. PubMed ID: 1293269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperkalaemia in renal failure with salbutamol inhalation.
    Montoliu J; Almirall J; Ponz E; Campistol JM; Revert L
    J Intern Med; 1990 Jul; 228(1):35-7. PubMed ID: 2384735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective disposition of salbutamol in man following oral and intravenous administration.
    Boulton DW; Fawcett JP
    Br J Clin Pharmacol; 1996 Jan; 41(1):35-40. PubMed ID: 8824691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.
    Jenkins CR; Marlin GE
    Br J Clin Pharmacol; 1981 Feb; 11(2):197-201. PubMed ID: 7011349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.